Behavioral studies of the abuse potential and anesthetic and sedative effects of etomidate in male rodents
Psychopharmacology · 2025
DOI: 10.1007/s00213-024-06715-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychopharmacology, 2025. Verfasst von Lixin Kuai und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China. Hauptthemen laut MEDLINE: Etomidate, Hypnotics and Sedatives, Behavior, Animal, Substance-Related Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Research Program on the Guiding Principles for the Formulation and Adjustment of the Control Level for Narcotic and Psychotropic Substances, Key Projects of National Key Research and Development Plan of China.
Abstract (Originalsprache)
RATIONALE: Etomidate is a short-acting general anesthetic for clinical use and has been used as alternative to propofol or added to the powdered drug and e-cigarette cartridges recently, leading to an increase in abuse. But there have been no studies conducted on the abuse potential of etomidate. OBJECTIVES AND METHODS: This study aimed to evaluate the abuse potential of etomidate via conditioned place preference (CPP) and self-administration tests, reflecting its rewarding and reinforcing effects. In addition, righting reflex and open-field tests were conducted to evaluate the anesthetic and sedative effects of etomidate. RESULTS: In male mice, the ED50 after intraperitoneal (i.p.) injection of anesthetic effect for etomidate was 9.156 mg/kg and the ED50 of the sedative effect 5 min after intraperitoneal injection was 2.389 mg/kg. Etomidate induced CPP in male mice at the minimum dose of 3 mg/kg i.p. and supported stable self-administration in male rats at the dose of 0.075 mg/kg/intravenous infusion. The dose-response curve of etomidate was an inverted U-shape, which showed significant self-administrations compared with the vehicle group at doses of 0.05-0.1 mg/kg/infusion etomidate and the highest intake of 21.1 ± 0.64 infusions per 4 h-session. CONCLUSIONS: These results clearly demonstrate that etomidate has rewarding and reinforcing effects in male rodents, as well as effects on anesthesia and motor inhibition. These findings indicate the possibility of abuse potential in humans using etomidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China.
- Office of China National Narcotics Control Commission, China Pharmaceutical University Joint Laboratory on Key Technologies of Narcotics Control, Beijing, China, 100193.
- Key Laboratory of Drug Monitoring and Control, Drug Intelligence and Forensic Center, Ministry of Public Security, Beijing, China, 100193.
- Chongqing Institute for Food and Drug Control, Chongqing, China, 401121.
- NMPA Key Laboratory of Quality Monitoring of Anaesthetic and Psychotropic Substances, Chongqing , China, 401121.
- School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China. 1020081879@cpu.edu.cn.
Förderung
- Research Program on the Guiding Principles for the Formulation and Adjustment of the Control Level for Narcotic and Psychotropic Substances
- Key Projects of National Key Research and Development Plan of China
Zitieren
APA
Kuai, L., Li, X., Xu, D., Zeng, L., Xu, P., Di, B., Yan, F., & Wang, D. (2025). Behavioral studies of the abuse potential and anesthetic and sedative effects of etomidate in male rodents. Psychopharmacology. https://doi.org/10.1007/s00213-024-06715-5
Vancouver
Kuai L, Li X, Xu D, Zeng L, Xu P, Di B, et al. Behavioral studies of the abuse potential and anesthetic and sedative effects of etomidate in male rodents. Psychopharmacology. 2025. doi:10.1007/s00213-024-06715-5
BibTeX
@article{Kuai2025,
author = {Kuai, Lixin and Li, Xiangyu and Xu, Deli and Zeng, Linggao and Xu, Peng and Di, Bin and Yan, Fang and Wang, Dan},
title = {Behavioral studies of the abuse potential and anesthetic and sedative effects of etomidate in male rodents},
journal = {Psychopharmacology},
year = {2025},
doi = {10.1007/s00213-024-06715-5}
}
EUVIMED